[Use of etoposide, ifosfamide and cisplatin (EIP) for treatment of inoperable non-small cell lung cancer].

Recent studies have pointed out that chemotherapy can prolong life in advanced inoperable cancer patients. A clinical study to evaluate response and toxicity of the combination of etoposide, ifosfamide and cisplatin (EIP) in the treatment of inoperable non-small cell lung cancer was performed. 25 patients entered the study.

[Hemothorax and retroperitoneal hematoma with the secondary posthemorrhagic anemia as a complication of oral anticoagulant and non-steroidal anti-inflammatory drug therapy].

The authors want to indicate, according to the case description, the danger of oral anticoagulants and nonsteroidal antiinflammatory drug's therapy in elderly patients.